This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paul Weiden, MD

Arch Intern Med. 1984;144(8):1557-1558.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Graft-v-host disease (GVHD) is the clinicopathologic syndrome that results from the reaction initiated by a "graft" of immunologically competent lymphocytes introduced into a "host" that confronts the graft with a histocompatibility difference, but is unable to mount an immunologic attack against the donor lymphoid cells. Although GVHD is most commonly recognized as a complication of allogeneic marrow transplantation, GVHD has also been reported following transfusion of nonirradiated blood products to patients with compromised immunologic function. Graft-v-host disease has been described in neonates who received intrauterine or exchange transfusions for hemolytic disease of the newborn,¹ in children with congenital immune deficiency or progressive vaccinia necrosum who were given fresh plasma or blood,² in patients with leukemia or lymphoma who were given granulocyte transfusions,^3,4 and in patients with neuroblastoma⁵ or Hodgkin's disease⁶ who were given transfusions of packed RBCs only.

Typically, a seemingly . . . [Full Text PDF of this Article]

Author Affiliations
Section of Hematology-Oncology The Mason Clinic 1100 Ninth Ave Seattle, WA 98101 Fred Hutchison Cancer Research Center Seattle

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?